Delivery Order SPE2DB24D1205-SPE2DB25FCRWC
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $1,018.25 firm fixed-price delivery order is for 4566437277 GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,690.42 firm fixed-price delivery order covers the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,330.04 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of 4,564,931,294 units of the drug Glimepiride 1 mg tablets, with a ceiling value of $4,046.78, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,322.54 Firm Fixed Price Delivery Order is for the provision of 4,564,326,421 tablets of the pharmaceutical drug Glimepiride 4 mg. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.31 firm-fixed-price delivery order is for 4,567,632,423 tablets of the medication Glimepiride 4 mg. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is a Delivery Order worth $1,176.98 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is for 4,567,171,215 tablets of the drug Glimepiride 4 mg. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Glimepiride tablets. The contract has a total ceiling value of $3,366.65 and is set to expire on February 11, 2025. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,247.78 firm fixed-price delivery order is for the supply of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, Corporate Office Division, a firm-fixed-price delivery order contract valued at $1,286.16 for the supply of 4,565,784,148 glimepiride 4 mg tablets. The contract has a completion date of September 13, 2024 and was awarded on September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and supplier of medical products to the U.S. federal government. This delivery order is part of the company's broader...